Sustained MYB Activity Is Necessary for Oncogenic Transcription in KMT2A-Rearranged Acute Lymphoblastic Leukemia through Enhancer-Promoter Interactions and Epigenetic Modifications at Enhancers
Lau J., Harman JR., Jackson NE., Denny N., Smith AL., Vyas P., Davies JO., Hughes J., Crump N., Milne TA.